DAPAGLIFLOZINA 5 MG COM REV CT BL AL/AL X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1053502580034
  • GGREM 517626090035607
  • Código de barras 7899620918313

O que a fonte publica

Detentor do registro
LABORATORIO GLOBO SA
Princípios ativos
DAPAGLIFLOZINA
Embalagem
5 MG COM REV CT BL AL/AL X 30
Regime de dispensação
Tarja Vermelha
Tipo de produto
Genérico
Classe terapêutica
A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:517626090035607
{
  "name": "DAPAGLIFLOZINA 5 MG COM REV CT BL AL/AL X 30",
  "holder": "LABORATORIO GLOBO SA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7899620918313"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "517626090035607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "17.115.437/0001-73",
  "priceRegime": "Regulado",
  "productName": "DAPAGLIFLOZINA",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "5 MG COM REV CT BL AL/AL X 30",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "46.75",
    "icms-12": "53.13",
    "icms-17": "56.33",
    "icms-18": "57.01",
    "icms-19": "57.72",
    "icms-20": "58.44",
    "icms-21": "59.18",
    "icms-22": "59.94",
    "icms-23": "60.71",
    "icms-17.5": "56.67",
    "icms-19.5": "58.07",
    "icms-20.5": "58.81",
    "icms-22.5": "60.32",
    "icms-12-alc": "52.49",
    "icms-17-alc": "55.65",
    "icms-18-alc": "56.33",
    "icms-19-alc": "57.02",
    "icms-20-alc": "57.74",
    "icms-21-alc": "58.47",
    "icms-22-alc": "59.22",
    "icms-23-alc": "59.99",
    "withoutTaxes": "46.19",
    "icms-17.5-alc": "55.99",
    "icms-19.5-alc": "57.38",
    "icms-20.5-alc": "58.10",
    "icms-22.5-alc": "59.60"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "DAPAGLIFLOZINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "64.44",
    "icms-12": "73.23",
    "icms-17": "77.65",
    "icms-18": "78.58",
    "icms-19": "79.56",
    "icms-20": "80.55",
    "icms-21": "81.57",
    "icms-22": "82.62",
    "icms-23": "83.68",
    "icms-17.5": "78.11",
    "icms-19.5": "80.04",
    "icms-20.5": "81.06",
    "icms-22.5": "83.14",
    "icms-12-alc": "72.56",
    "icms-17-alc": "76.93",
    "icms-18-alc": "77.87",
    "icms-19-alc": "78.83",
    "icms-20-alc": "79.82",
    "icms-21-alc": "80.83",
    "icms-22-alc": "81.87",
    "icms-23-alc": "82.93",
    "withoutTaxes": "63.85",
    "icms-17.5-alc": "77.40",
    "icms-19.5-alc": "79.32",
    "icms-20.5-alc": "80.32",
    "icms-22.5-alc": "82.39"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "DAPAGLIFLOZINA"
  ],
  "therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1053502580034",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "A10P1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:517626090035607"